ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: hip OA

Calcium Pyrophosphate Deposition Disease Diagnosis & Treatment Gaps Remain

  |  

CPPD diagnosis is difficult & treatments are limited. Experts review radiology challenges, off-label options like colchicine, & emerging biologics.

Meeting Management Challenges in axSpA

  |  

At this ACR Convergence 2025 session, experts discussed emerging concepts with axial spondyloarthritis, including the most effective MRI specifications for diagnosis, challenges with axial juvenile spondyloarthritis & the many mimics of axSpA.

Dr. Tait Shanafelt, with ACR President Dr. Carol Langford

A Focus on Wellness; Keynote Speaker Tait Shananfelt, MD, Shared Causes of Occupational Burnout & Pearls to Prevent It

  |  

This year’s Opening Session of ACR Convergence 2025 featured a well-known thought leader on physician burnout, Dr. Tait Shanafelt, who provided insight into the risk of burnout and how to prevent it. Key leadership also addressed research advocacy and more.

Meet Incoming ARP President Rebecca Cleveland

Leslie Mertz, PhD  |  

Incoming ARP President Dr. Rebecca Cleveland discusses her plans for advocacy, ACR/ARP collaboration, & tackling workforce shortages in rheumatology.

Gout & Cardiometabolic Co-Morbidities

  |  

ACR Convergence 2025 experts explore gout’s deep ties to MetS, insulin resistance and cardiovascular mortality, weighing new data on colchicine, febuxostat and SGLT2 inhibitors.